Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04543461

American Lung Association (ALA) Lung Health Cohort

The American Lung Association (ALA) Lung Health Cohort

Status
Recruiting
Phase
Study type
Observational
Enrollment
4,000 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
25 Years – 35 Years
Healthy volunteers
Accepted

Summary

The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.

Detailed description

The scientific goal of the study is to establish the relationship between a variety of factors (lifetime environmental exposures, fitness and physical activity, biomarkers, nasal respiratory epithelial transcriptome) and ideal versus impaired peak lung health (reserve and markers of susceptibility in investigators' model) in young adulthood. In addition to the initial baseline assessment, remote contacts (e.g., via text message, email, mail, or phone) at regular intervals will allow for both the retention of the participants as well as the collection of additional short-term follow-up information, i.e., within 4.5 years of enrollment. If additional funding becomes available, investigators will extend the study for an additional period of time to study factors related to long-term changes in lung health over time, i.e., at 5 years and beyond. Recruitment of participants will be conducted by the participating study sites along with national and regional efforts from the American Lung Association. Recruitment efforts will be supported by the study web site www.lung.org/lung-study

Conditions

Timeline

Start date
2021-10-29
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2020-09-10
Last updated
2026-02-04

Locations

37 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04543461. Inclusion in this directory is not an endorsement.